nimodipine has been researched along with Day Blindness in 6 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Susac's syndrome is an extremely rare clinical manifestation characterized by the triad of fluctuating sensorineural hearing loss, sudden visual loss and encephalopathy." | 2.41 | [Susac syndrome as a cause of sensorineural hearing loss]. ( Albaladejo Devis, I; Cubillana Herrero, JD; Jiménez Cervantes-Nicolás, JA; Minguez Merlos, N; Rodríguez González-Herrero, B; Soler Valcárcel, A, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fortini, A | 1 |
| Cincotta, M | 1 |
| Faraone, A | 1 |
| Baruffi, C | 1 |
| Carrieri, G | 1 |
| Limbucci, N | 1 |
| Boccadori, C | 1 |
| Nenci, G | 1 |
| Beccia, M | 1 |
| Ceschin, V | 1 |
| Bozzao, A | 1 |
| Romano, A | 1 |
| Biraschi, F | 1 |
| Fantozzi, LM | 1 |
| Rasura, M | 1 |
| Chatterjee, N | 1 |
| Domoto-Reilly, K | 1 |
| Fecci, PE | 1 |
| Schwamm, LH | 1 |
| Singhal, AB | 1 |
| Cubillana Herrero, JD | 1 |
| Soler Valcárcel, A | 1 |
| Albaladejo Devis, I | 1 |
| Rodríguez González-Herrero, B | 1 |
| Minguez Merlos, N | 1 |
| Jiménez Cervantes-Nicolás, JA | 1 |
| Woolridge, D | 1 |
| Stefanelli, M | 1 |
| Hoppe, B | 1 |
| Wildemann, B | 1 |
| Schülin, C | 1 |
| Storch-Hagenlocher, B | 1 |
| Hacke, W | 1 |
| Dithmar, S | 1 |
| Kirchhof, K | 1 |
| Jansen, O | 1 |
| Breitbart, A | 1 |
1 review available for nimodipine and Day Blindness
| Article | Year |
|---|---|
[Susac syndrome as a cause of sensorineural hearing loss].
Topics: Adult; Anti-Inflammatory Agents; Aspirin; Cerebral Infarction; Cochlea; Combined Modality Therapy; D | 2002 |
5 other studies available for nimodipine and Day Blindness
| Article | Year |
|---|---|
Headache and visual impairment after twin birth: a challenging diagnosis.
Topics: Adult; Cerebral Arteries; Female; Headache; Humans; Injections, Intra-Arterial; Magnetic Resonance A | 2017 |
Headache and visual symptoms in two patients with MRI alterations in posterior cerebral artery territory.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Clopidogrel; Diagnosis, Differential; Diffusion Magnetic | 2009 |
Licorice-associated reversible cerebral vasoconstriction with PRES.
Topics: Administration, Oral; Brain; Cerebral Angiography; Cerebrovascular Circulation; Cerebrovascular Diso | 2010 |
Susac syndrome with frontal intermittent rhythmic delta activity (FIRDA).
Topics: Adult; Brain Diseases; Calcium Channel Blockers; Delta Rhythm; Gait Disorders, Neurologic; Hearing L | 2006 |
Susac's syndrome: improvement with combined antiplatelet and calcium antagonist therapy.
Topics: Adult; Aspirin; Calcium Channel Blockers; Cerebrovascular Disorders; Drug Combinations; Female; Hear | 1996 |